This January and February, Bio-Techne presents a series of conference-level talks based on key advances in Bioconjugation.

Join us on 17th January at 4pm GMT for the first of 3 exceptional presentations by established speakers in the field. Register here for the timetable and to receive email updates about the conference.

During this session, Dr Richards will talk about methods for generating protein–nanomaterial conjugates, before going on to discuss their potential therapeutic and diagnostic applications. Particular attention will be given to emerging chemical methods that developed in the lab, and exciting ways in which novel synthetic proteins are incorporated into research work. Dr Richards will also discuss emerging trends in protein–nanomaterial conjugation, and how these could allow to overcome current hurdles in the field

Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results.  Let us help you achieve success.

To ask questions during the event, please click the 'Raise Hand' icon or submit a written question on slido.com using the code #R17012.
Date and Time
Monday, January 17, 2022 4:00 PM 04:00 pm - 05:00 pm GMT+0
Speakers Avatar Dr Daniel Richards
Dr Daniel Richards is a co-investigator on the BRCCH-funded DAVINCI project and will be leading the effort at ETH Zurich to develop a smartphone app capable of analysing and interpreting the project’s SARS-CoV-2 test. Dr Richards joined the deMello group at ETH Zurich as a Marie Skłodowska-Curie Fellow in early 2020 and has since focused on exploring the interface of synthetic biology, diagnostics and microfluidics. He has an active interest in point-of-care diagnostics, protein modification, synthetic biology and nanomaterials. Prior to joining ETH Zurich, Dr Richards was a postdoctoral researcher at Imperial College London, UK, where he was involved in developing nanomaterial-based diagnostic technologies for both infectious and non-infectious diseases. He completed his PhD at University College London, where he focused on applying novel chemical reactions to complex proteins with the aim of improving the functionality of therapeutically relevant biomolecules.

DOI: BmGfdCIxmlwL47f7uKAP_prepost_1

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.